← Back to Search

Best Practice Advisory Alerts for Heart Failure (PROMPTHF-Inova Trial)

N/A

Recruiting

Led By Mitchell Psotka, MD, PhD

Research Sponsored by Inova Health Care Services

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Left Ventricular Ejection Fraction ≤40%

Age > 18 Years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

PROMPTHF-Inova Trial Summary

This trial will test whether an electronic best practice advisory system, which notifies clinicians of guideline-indicated and FDA-approved heart failure medications currently not prescribed to their patients, is more effective than usual care in stimulating appropriate medication prescription for patients with heart failure and a reduced ejection fraction.

Who is the study for?

This trial is for heart failure patients over 18 years old with a left ventricular ejection fraction of 40% or less, seen by a cardiologist at Inova clinics or hospitals. It's not for those who've opted out of EHR research, had a heart transplant, are on full doses of HFrEF meds, or in hospice care.Check my eligibility

What is being tested?

The study tests if an electronic alert system helps doctors prescribe the right FDA-approved heart failure meds versus usual care without alerts. Patients will be randomly assigned to receive either the new alert system approach or continue with standard practices.See study design

What are the potential side effects?

Since this trial involves an electronic health record intervention rather than medication, there are no direct side effects from drugs being tested. However, changes in medication prescription patterns could indirectly affect patient outcomes.

PROMPTHF-Inova Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My heart's pumping ability is reduced.

Select...

I am older than 18 years.

PROMPTHF-Inova Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Increased use of GDMT in patients with Heart Failure with Reduced Ejection Fraction

Secondary outcome measures

All-cause hospitalization and all-cause mortality at 1 year

Perinatal death

+1 more

PROMPTHF-Inova Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Alert when provider is entering ordersExperimental Treatment1 Intervention

Group II: No alert, usual careActive Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Heart Failure CollaboratoryUNKNOWN

Inova Health Care ServicesLead Sponsor

69 Previous Clinical Trials

17,259 Total Patients Enrolled

3 Trials studying Heart Failure

210 Patients Enrolled for Heart Failure

Mitchell Psotka, MD, PhDPrincipal InvestigatorInova Health Care Services

Media Library

Best Practice Advisory using Electronic Health Record Clinical Trial Eligibility Overview. Trial Name: NCT05433220 — N/A

Heart Failure Research Study Groups: Alert when provider is entering orders, No alert, usual care

Heart Failure Clinical Trial 2023: Best Practice Advisory using Electronic Health Record Highlights & Side Effects. Trial Name: NCT05433220 — N/A

Best Practice Advisory using Electronic Health Record 2023 Treatment Timeline for Medical Study. Trial Name: NCT05433220 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are undergoing treatment in this clinical experiment?

"Affirmative. The clinical trial is actively recruiting patients, as evidenced by the information found onclinicaltrials.gov. This data-driven study was first published on August 25th 2022 and most recently updated on September 23rd 2022, with a mission to enroll 5,000 participants from one medical site."

Answered by AI

Are there available positions for participants in this experiment?

"Clinicaltrials.gov reveals that this clinical trial is ongoing, with the initial posting being on August 25th 2022 and the most recent update occurring on September 23rd 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova

Mitchell Psotka, MD, Ph.D 2022. "PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05433220.